ORINY News and Press, Orion Corp ADR From 07/31/23

2023-07-31 16:54:37 ET Marinus Pharmaceuticals ( NASDAQ: MRNS ) and partner Orion Oyj ( OTCPK:ORINY ) said that the European Commission has granted market approval for Marinus's drug Ztalmy as an adjunctive treatment for epileptic seizures in children with CDKL5 deficiency disor...

Orion Oyj (ORINF) Q2 2022 Results Conference Call July 15, 2022 6:30 AM ET Company Participants Tuukka Hirvonen - Head, IR Timo Lappalainen - CEO Jari Karlson - CFO Conference Call Participants Jo Walton - Credit Suisse Sami Sarkamies - Danske Ban...

The following slide deck was published by Orion Oyj in conjunction with their 2022 Q2 earnings call. For further details see: Orion Oyj 2022 Q2 - Results - Earnings Call Presentation

Orion Corporation (OTCPK:ORINY) to acquire Belgian based Inovet BV and its wholly owned subsidiary V.M.D. NV and all companies belonging to V.M.D. NV’s group of companies for ~EUR 130M debt free. VMD is a veterinary pharmaceuticals company specialised in medicines and health ...

Orion Oyj (ORINF) Q1 2022 Results Conference Call April 28, 2022 06:30 AM ET Company Participants Tuukka Hirvonen - Head, IR Timo Lappalainen - CEO Jari Karlson - CFO Conference Call Participants Harry Sephton - Credit Suisse Sami Sarkamies - Danske Bank Presentation Tuukka Hirvonen Good afte...

My portfolio crossed the mark where I could lock in capital gains, switch decidedly to income stocks and retire today. That is, if these income stocks yield at least some 4.5%. Yield is easy to find, but can it be relied on? For further details see: High Yield And Low Co...

AstraZeneca's innovative culture earned it a place as one of the leading biotechs globally. Revenue growth from COVID vaccine sales and some key markets provide strong tailwinds for the company's share in the second half of 2021. Most of AstraZeneca's revenue comes from a handful ...